What is HAPPE Spine?
Founded in 2018 and headquartered in Holland, Michigan, HAPPE Spine operates at the intersection of material science and orthopedic surgery. The company specializes in the design and development of advanced spinal implants that leverage the unique HAPPE orthopedic material platform. By focusing on high-performance, biocompatible materials, HAPPE Spine aims to improve patient outcomes in spinal fusion and stabilization procedures. Their market position is defined by a commitment to rigorous engineering and clinical efficacy, positioning them as a specialized player in the competitive medical device landscape.
How much funding has HAPPE Spine raised?
HAPPE Spine has raised a total of $3.4M across 1 funding round:
Series A
$3.4M
Series A (2021): $3.4M with participation from Genesis Innovation Group
Key Investors in HAPPE Spine
Genesis Innovation Group
Genesis Innovation Group is a specialized firm focused on medical device development and innovation services, providing end-to-end support from ideation to market strategy for healthcare entrepreneurs.
What's next for HAPPE Spine?
With the recent strategic investment, HAPPE Spine is poised to transition from its early-stage development phase into a more robust commercial scaling operation. The capital will likely be deployed to expand manufacturing capabilities, navigate complex regulatory pathways, and broaden the clinical adoption of their spinal implant portfolio. As the company matures, the focus will shift toward establishing long-term partnerships with healthcare providers and orthopedic surgeons, ensuring that their innovative material technology becomes a standard in spinal care. This growth trajectory suggests a clear intent to capture significant market share within the orthopedic implant industry.
See full HAPPE Spine company page
